Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSPCs Therapy for Rotator Cuff Tears
NCT07320378Phase 1Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2026
- Primary completion
- Jun 2028
01
Overview
Phase 1 trial in rotator cuff tendinopathy (RCT) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Incidence and severity of cell therapy related adverse events at 12 weeks and Oxford Shoulder Score at 24 weeks. Planned start May 2026; status: not yet recruiting.
02
Conditions
rotator cuff tendinopathy (RCT)
Beyond the preview
Go deeper on NCT07320378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07320378.